Contrary to current guidelines, a majority of American primary care physicians are ordering some form of lung cancer screening test for patients who lack any symptoms of disease, a new national survey reveals.
The findings stems from responses to a questionnaire completed by 962 family physicians, general practitioners and general internists between 2006 and 2007.
"There is no authoritative group that is recommending lung cancer screening for asymptomatic individuals," said study author Carrie Klabunde, an epidemiologist from the applied research program within the division of cancer control and population sciences at the U.S. National Cancer Institute.
Read the full story: http://hcp.lv/z7jgwx
Source: HealthDay/US News
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen